Latest Posts

• Avelas Bio Raises $7.65M to Advance Fluorescing Diagnostic for Cancer

  San Diego’s Avelas Biosciences says today it has closed on $7.65 million in a Series A financing round—raised entirely from San Diego-based Avalon Ventures—to advance the use of fluorescing tags that change color in the presence of cancer cells. The technology, developed by... Read more »

  Bruce V. Bigelow12/6/12

  • San Diego

  • Life Sciences

  • cancer

  • Diagnostics

• Angle and Yang to Demo Telepresence Robot at Health IT Forum Dec. 10

  Healthcare will no doubt shape the future of our country. And, if iRobot and InTouch Health succeed, robots may shape the future of healthcare.

  As Greg Huang wrote in September, iRobot has entered the healthcare field with the RP-VITA (Remote Presence Virtual... Read more »

  Thea Bissell12/6/12

  • Boston

  • events

  • Xconomy

  • healthcare

• Moderna, $40M in Tow, Hopes to Reinvent Biotech with “Make Your Own Drug”

  Noubar Afeyan, Bob Langer, Tim Springer, and a host of other Boston biotech luminaries have been sitting on a big secret. Today we’re going to out them.

  Moderna Therapeutics, a stealthy startup in Cambridge, MA, is the subject of their considerable brainpower and experiments.... Read more »

  Gregory T. Huang12/6/12

  • Boston

  • Biotech

  • Life Sciences

  • startups

• NanoString Pockets $15.3M For Diagnostic Rollout

  Seattle-based NanoString Technologies has pulled in another $15.3 million in investment cash to help build momentum for its new foray into the molecular diagnostic business.

  NanoString said Monday it took in $15.3 million in a Series E sale of preferred stock. Morgan Stanley... Read more »

  Luke Timmerman12/4/12

  • Seattle

  • Biotech

  • Diagnostics

  • VC

• HHS CTO Bryan Sivak on How Government Can Spur Healthcare Innovation

  It’s not every entrepreneur who even entertains the notion of moving from business to government. Bryan Sivak, though, has made the shift three times over. Sivak left his job at the company he helped create for a position in city government (as... Read more »

  Robert Buderi12/4/12

  • healthcare

  • Government

  • innovation

• Flexion Therapeutics Secures $20 Million to Fight Osteoarthritis

  [Corrected 12/04/12, 9:08 a.m. See below.] Flexion Therapeutics, based in Woburn, MA, said today that it has raised $20 million in a Series B financing led by Novo Ventures, a new investor. Flexion CEO Michael Clayman told me that the... Read more »

  Catherine Arnst12/4/12

  • Boston

  • deals

  • Biotech

  • Flexion Therapeutics

• San Diego’s Volcano Paying $36M+ for Menlo Park’s Crux Biomed

  San Diego vascular device maker Volcano Corp. (NASDAQ: VOLC) today disclosed an agreement to pay at least $36 million for Menlo Park, CA-based Crux Biomedical. The Crux deal comes just a few weeks after Volcano said it was acquiring Israeli imaging... Read more »

  Bruce V. Bigelow12/3/12

  • San Diego

  • Life Sciences

  • medical devices

  • Pulmonary Embolisms

Read More Posts ›